Neutralizing antibody responses against contemporary and future influenza A(H3N2) viruses in paradoxical clades elicited by repeated and single vaccinations

被引:1
|
作者
Zhang, Ting [1 ,2 ,3 ,4 ]
Han, Yang [2 ,3 ,4 ,5 ,6 ]
Huang, Weijuan [2 ]
Wei, Hejiang [2 ]
Zhao, Yingze [2 ,3 ,4 ]
Shu, Liumei [7 ]
Guo, Yaxin [2 ,3 ,4 ]
Ye, Beiwei [2 ,3 ,4 ]
Zhou, Jianfang [2 ]
Liu, Jun [1 ,2 ,3 ,4 ]
机构
[1] Guangxi Med Univ, Collaborat Innovat Ctr Regenerat Med & Med Biores, Applicat Coconstructed Prov & Minist, Nanning, Peoples R China
[2] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Natl Key Lab Intelligent Tracking & Forecasting I, Beijing, Peoples R China
[3] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, NHC Key Lab Biosafety, Beijing, Peoples R China
[4] Chinese Acad Med Sci, Res Unit Adapt Evolut & Control Emerging Viruses, Beijing, Peoples R China
[5] Wenzhou Med Univ, Eye Hosp, Natl Clin Res Ctr Ocular Dis, Wenzhou, Peoples R China
[6] Wenzhou Med Univ, Eye Hosp, State Key Lab Ophthalmol Optometry & Visual Sci, Wenzhou, Peoples R China
[7] Beijing Daxing Dist Hosp, Dept Hlth Care, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
B antigenic sites; B cell receptor repertoire; neutralizing antibody; repeated vaccination; VACCINE EFFECTIVENESS; HEMAGGLUTININ RESIDUES; SERIAL VACCINATION; RECEPTOR-BINDING; B-CELLS; REPERTOIRES; EFFICACY; IDENTIFICATION; METAANALYSIS; PROTECTION;
D O I
10.1002/jmv.29743
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
As one of the most effective measures to prevent seasonal influenza viruses, annual influenza vaccination is globally recommended. Nevertheless, evidence regarding the impact of repeated vaccination to contemporary and future influenza has been inconclusive. A total of 100 subjects singly or repeatedly immunized with influenza vaccines including 3C.2a1 or 3C.3a1 A(H3N2) during 2018-2019 and 2019-2020 influenza season were recruited. We investigated neutralization antibody by microneutralization assay using four antigenically distinct A(H3N2) viruses circulating from 2018 to 2023, and tracked the dynamics of B cell receptor (BCR) repertoire for consecutive vaccinations. We found that vaccination elicited cross-reactive antibody responses against future emerging strains. Broader neutralizing antibodies to A(H3N2) viruses and more diverse BCR repertoires were observed in the repeated vaccination. Meanwhile, a higher frequency of BCR sequences shared among the repeated-vaccinated individuals with consistently boosting antibody response was found than those with a reduced antibody response. Our findings suggest that repeated seasonal vaccination could broaden the breadth of antibody responses, which may improve vaccine protection against future emerging viruses.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Trivalent influenza vaccine-induced antibody response to circulating influenza a (H3N2) viruses in 2010/11 and 2011/12 seasons
    Hiroi, Satoshi
    Morikawa, Saeko
    Nakata, Keiko
    Maeda, Akiko
    Kanno, Tsuneji
    Irie, Shin
    Ohfuji, Satoko
    Hirota, Yoshio
    Kase, Tetsuo
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (02) : 386 - 390
  • [32] Enhancement of immune responses to influenza vaccine (H3N2) by ginsenoside Re
    Song, Xiaoming
    Chen, Jian
    Sakwiwatkul, Kedsirin
    Li, Ruili
    Hu, Songhua
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2010, 10 (03) : 351 - 356
  • [33] A novel neutralizing antibody against diverse clades of H5N1 influenza virus and its mutants capable of airborne transmission
    Wu, Ruiping
    Li, Xingxing
    Leung, Ho-Chuen
    Cao, Zhiliang
    Qiu, Zonglin
    Zhou, Yusen
    Zheng, Bo-Jian
    He, Yuxian
    ANTIVIRAL RESEARCH, 2014, 106 : 13 - 23
  • [34] Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA
    Portnoff, Alyse D.
    Patel, Nita
    Massare, Michael J.
    Zhou, Haixia
    Tian, Jing-Hui
    Zhou, Bin
    Shinde, Vivek
    Glenn, Gregory M.
    Smith, Gale
    VACCINES, 2020, 8 (01)
  • [35] Trivalent inactivated influenza vaccine effective against influenza A(H3N2) variant viruses in children during the 2014/15 season, Japan
    Sugaya, N.
    Shinjoh, M.
    Kawakami, C.
    Yamaguchi, Y.
    Yoshida, M.
    Baba, H.
    Ishikawa, M.
    Kono, M.
    Sekiguchi, S.
    Kimiya, T.
    Mitamura, K.
    Fujino, M.
    Komiyama, O.
    Yoshida, N.
    Tsunematsu, K.
    Narabayashi, A.
    Nakata, Y.
    Sato, A.
    Taguchi, N.
    Fujita, H.
    Toki, M.
    Myokai, M.
    Ookawara, I.
    Takahashi, T.
    EUROSURVEILLANCE, 2016, 21 (42) : 2 - 14
  • [36] A Bayesian approach to incorporate structural data into the mapping of genotype to antigenic phenotype of influenza A(H3N2) viruses
    Harvey, William T.
    Davies, Vinny
    Daniels, Rodney S.
    Whittaker, Lynne
    Gregory, Victoria
    Hay, Alan J.
    Husmeier, Dirk
    McCauley, John W.
    Reeve, Richard
    PLOS COMPUTATIONAL BIOLOGY, 2023, 19 (03)
  • [37] Human Monoclonal Antibodies to Pandemic 1957 H2N2 and Pandemic 1968 H3N2 Influenza Viruses
    Krause, Jens C.
    Tsibane, Tshidi
    Tumpey, Terrence M.
    Huffman, Chelsey J.
    Albrecht, Randy
    Blum, David L.
    Ramos, Irene
    Fernandez-Sesma, Ana
    Edwards, Kathryn M.
    Garcia-Sastre, Adolfo
    Basler, Christopher F.
    Crowe, James E., Jr.
    JOURNAL OF VIROLOGY, 2012, 86 (11) : 6334 - 6340
  • [38] Ferret model to mimic the sequential exposure of humans to historical H3N2 influenza viruses
    Chiba, Shiho
    Hatta, Masato
    Pattinson, David
    Yasuhara, Atsuhiro
    Neumann, Gabriele
    Kawaoka, Yoshihiro
    VACCINE, 2023, 41 (02) : 590 - 597
  • [39] Localization of epitopes recognized by monoclonal antibodies that neutralized the H3N2 influenza viruses in man
    Okada, Jun
    Ohshima, Nobuko
    Kubota-Koketsu, Ritsuko
    Iba, Yoshitaka
    Ota, Sayuri
    Takase, Wakana
    Yoshikawa, Tetsushi
    Ishikawa, Toyokazu
    Asano, Yoshizo
    Okuno, Yoshinobu
    Kurosawa, Yoshikazu
    JOURNAL OF GENERAL VIROLOGY, 2011, 92 : 326 - 335
  • [40] Comparison of Human H3N2 Antibody Responses Elicited by Egg-Based, Cell-Based, and Recombinant Protein-Based Influenza Vaccines During the 2017-2018 Season
    Gouma, Sigrid
    Zost, Seth J.
    Parkhouse, Kaela
    Branche, Angela
    Topham, David J.
    Cobey, Sarah
    Hensley, Scott E.
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (06) : 1447 - 1453